Global Radiopharmaceuticals in Nuclear Medicine Sales Market Report 2020 by Manufacturer, Region, Type and Application

Global Radiopharmaceuticals in Nuclear Medicine Sales Market Report 2020 by Manufacturer, Region, Type and Application

Table of Contents

1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 Radiopharmaceuticals in Nuclear Medicine Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Diagnostic Radiopharmaceuticals
2.1.2 Therapy Radiopharmaceuticals
2.1.3 Enriched Stable Isotopes
2.2 Overall Market Performance(Value)
2.2.1 Diagnostic Radiopharmaceuticals
2.2.2 Therapy Radiopharmaceuticals
2.2.3 Enriched Stable Isotopes
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Diagnostic Application
3.1.2 Therapeutic Application
3.1.3 Research
3.1.4 Pharmaceutical
3.1.5 Other
4 Manufacturers Profiles/Analysis
4.1 Bracco Imaging S.P.A.
4.1.1 Bracco Imaging S.P.A. Profiles
4.1.2 Bracco Imaging S.P.A. Product Information
4.1.3 Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 Bracco Imaging S.P.A. SWOT Analysis
4.2 Cambridge Isotope Laboratories, Inc.
4.2.1 Cambridge Isotope Laboratories, Inc. Profiles
4.2.2 Cambridge Isotope Laboratories, Inc. Product Information
4.2.3 Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear MedicineSales, Sales Value (Million USD), Price and Gross Profit
4.2.4 Cambridge Isotope Laboratories, Inc. SWOT Analysis
4.3 Cardinal Health, Inc.
4.3.1 Cardinal Health, Inc. Profiles
4.3.2 Cardinal Health, Inc. Product Information
4.3.3 Cardinal Health, Inc. Radiopharmaceuticals in Nuclear MedicineSales, Sales Value (Million USD), Price and Gross Profit
4.3.4 Cardinal Health, Inc. SWOT Analysis
4.4 Covidien, Plc
4.4.1 Covidien, Plc Profiles
4.4.2 Covidien, Plc Product Information
4.4.3 Covidien, Plc Radiopharmaceuticals in Nuclear MedicineSales, Sales Value (Million USD), Price and Gross Profit
4.4.4 Covidien, Plc SWOT Analysis
4.5 Eczacibasi-Monrol
4.5.1 Eczacibasi-Monrol Profiles
4.5.2 Eczacibasi-Monrol Product Information
4.5.3 Eczacibasi-Monrol Radiopharmaceuticals in Nuclear MedicineSales, Sales Value (Million USD), Price and Gross Profit
4.5.4 Eczacibasi-Monrol SWOT Analysis
4.6 Fujifilm Holdings Corporation
4.6.1 Fujifilm Holdings Corporation Profiles
4.6.2 Fujifilm Holdings Corporation Product Information
4.6.3 Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear MedicineSales, Sales Value (Million USD), Price and Gross Profit
4.6.4 Fujifilm Holdings Corporation SWOT Analysis
4.7 GE Healthcare (Subsidiary Of General Electric Company)
4.7.1 GE Healthcare (Subsidiary Of General Electric Company) Profiles
4.7.2 GE Healthcare (Subsidiary Of General Electric Company) Product Information
4.7.3 GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear MedicineSales, Sales Value (Million USD), Price and Gross Profit
4.7.4 GE Healthcare (Subsidiary Of General Electric Company) SWOT Analysis
4.8 IBA Group
4.8.1 IBA Group Profiles
4.8.2 IBA Group Product Information
4.8.3 IBA Group Radiopharmaceuticals in Nuclear MedicineSales, Sales Value (Million USD), Price and Gross Profit
4.8.4 IBA Group SWOT Analysis
4.9 Isotec, Inc. (Sigma-Aldrich)
4.9.1 Isotec, Inc. (Sigma-Aldrich) Profiles
4.9.2 Isotec, Inc. (Sigma-Aldrich) Product Information
4.9.3 Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear MedicineSales, Sales Value (Million USD), Price and Gross Profit
4.9.4 Isotec, Inc. (Sigma-Aldrich) SWOT Analysis
4.10 Lantheus Medical Imaging, Inc.
4.10.1 Lantheus Medical Imaging, Inc. Profiles
4.10.2 Lantheus Medical Imaging, Inc. Product Information
4.10.3 Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear MedicineSales, Sales Value (Million USD), Price and Gross Profit
4.10.4 Lantheus Medical Imaging, Inc. SWOT Analysis
4.11 Nordion, Inc.
4.12 Ntp Radioisotopes (Pty), Ltd.
4.13 Siemens Healthcare (Subsidiary Of Siemens AG)
4.14 Taiyo Nippon Sanso Corporation
4.15 Urenco Limited
4.16 Rotem Industries, Ltd., Inc.
4.17 Australian Nuclear Association And Technology Organization (ANSTO)
4.18 Board of Radiation And Isotope Technology (BRIT)
4.19 Institute of Atomic Energy Polatom Radioisotope Centre
4.20 Institute of Isotopes Co., Ltd.
4.21 Institute Of Radioelement (IRE)
5 Market Performance for Manufacturers
5.1 Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global Radiopharmaceuticals in Nuclear Medicine Market Assessment by Regions (2014-2020)
7.1 Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) by Regions 2014-2020
7.4 Global Radiopharmaceuticals in Nuclear Medicine Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global Radiopharmaceuticals in Nuclear Medicine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China Radiopharmaceuticals in Nuclear Medicine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA Radiopharmaceuticals in Nuclear Medicine Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe Radiopharmaceuticals in Nuclear Medicine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan Radiopharmaceuticals in Nuclear Medicine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea Radiopharmaceuticals in Nuclear Medicine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India Radiopharmaceuticals in Nuclear Medicine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Diagnostic Application Industry
11.2 Therapeutic Application Industry
11.3 Research Industry
11.4 Pharmaceutical Industry
11.5 Other Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) and Growth Rate 2021-2026
12.1.3 China Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Diagnostic Radiopharmaceuticals
12.2.3 Therapy Radiopharmaceuticals
12.2.4 Enriched Stable Isotopes
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Diagnostic Application
12.3.3 Therapeutic Application
12.3.4 Research
12.3.5 Pharmaceutical
12.3.6 Other
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) Trend 2021-2026
12.4.2 Global Radiopharmaceuticals in Nuclear Medicine Gross Profit Trend 2021-2026
13 Conclusion

List of Tables and Figures

Figure Product Picture of Radiopharmaceuticals in Nuclear Medicine
Table Product Specifications of Radiopharmaceuticals in Nuclear Medicine
Table Manufacturers List in the Report
Table Manufacturers Production Market Share (%) 2014-2020
Table Regions Overview in 2020
Table Product Type and Standard
Table Type Overview in 2020
Table Product Application and Standard
Table Application Overview in 2020
Figure Industry Chain Structure of Radiopharmaceuticals in Nuclear Medicine
Table Industry News List of Radiopharmaceuticals in Nuclear Medicine
Table Key Challenges
Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Types
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) by Types in 2014
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) by Types in 2020
Table Diagnostic Radiopharmaceuticals Sales (K Units) and Growth Rate
Figure Diagnostic Radiopharmaceuticals Sales (K Units) and Growth Rate
Table Therapy Radiopharmaceuticals Sales (K Units) and Growth Rate
Figure Therapy Radiopharmaceuticals Sales (K Units) and Growth Rate
Table Enriched Stable Isotopes Sales (K Units) and Growth Rate
Figure Enriched Stable Isotopes Sales (K Units) and Growth Rate
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) by Types
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) by Types in 2014
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) by Types in 2020
Table Diagnostic Radiopharmaceuticals Revenue (M USD) and Growth Rate
Figure Diagnostic Radiopharmaceuticals Revenue (M USD) and Growth Rate
Table Therapy Radiopharmaceuticals Revenue (M USD) and Growth Rate
Figure Therapy Radiopharmaceuticals Revenue (M USD) and Growth Rate
Table Enriched Stable Isotopes Revenue (M USD) and Growth Rate
Figure Enriched Stable Isotopes Revenue (M USD) and Growth Rate
Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) by Application 2014-2020
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) by Application in 2014
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) by Application in 2020
Table Diagnostic Application Sales (K Units) and Growth Rate 2014-2020
Figure Diagnostic Application Sales (K Units) and Growth Rate 2014-2020
Table Therapeutic Application Sales (K Units) and Growth Rate 2014-2020
Figure Therapeutic Application Sales (K Units) and Growth Rate 2014-2020
Table Research Sales (K Units) and Growth Rate 2014-2020
Figure Research Sales (K Units) and Growth Rate 2014-2020
Table Pharmaceutical Sales (K Units) and Growth Rate 2014-2020
Figure Pharmaceutical Sales (K Units) and Growth Rate 2014-2020
Table Other Sales (K Units) and Growth Rate 2014-2020
Figure Other Sales (K Units) and Growth Rate 2014-2020
Table Bracco Imaging S.P.A. Profiles
Table Bracco Imaging S.P.A. Product Information
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Sales Change 2014-2020
Table Bracco Imaging S.P.A. Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Cambridge Isotope Laboratories, Inc. Profiles
Table Cambridge Isotope Laboratories, Inc. Product Information
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Change 2014-2020
Table Cambridge Isotope Laboratories, Inc. Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Cardinal Health, Inc. Profiles
Table Cardinal Health, Inc. Product Information
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Change 2014-2020
Table Cardinal Health, Inc. Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Covidien, Plc Profiles
Table Covidien, Plc Product Information
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Sales Change 2014-2020
Table Covidien, Plc Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Eczacibasi-Monrol Profiles
Table Eczacibasi-Monrol Product Information
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Sales Change 2014-2020
Table Eczacibasi-Monrol Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Fujifilm Holdings Corporation Profiles
Table Fujifilm Holdings Corporation Product Information
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Sales Change 2014-2020
Table Fujifilm Holdings Corporation Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table GE Healthcare (Subsidiary Of General Electric Company) Profiles
Table GE Healthcare (Subsidiary Of General Electric Company) Product Information
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Sales Change 2014-2020
Table GE Healthcare (Subsidiary Of General Electric Company) Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table IBA Group Profiles
Table IBA Group Product Information
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Sales Change 2014-2020
Table IBA Group Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Isotec, Inc. (Sigma-Aldrich) Profiles
Table Isotec, Inc. (Sigma-Aldrich) Product Information
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Sales Change 2014-2020
Table Isotec, Inc. (Sigma-Aldrich) Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table Lantheus Medical Imaging, Inc. Profiles
Table Lantheus Medical Imaging, Inc. Product Information
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Sales Change 2014-2020
Table Lantheus Medical Imaging, Inc. Radiopharmaceuticals in Nuclear Medicine Market Status Change 2014-2020
Table …...
Table Global Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers 2014-2020
Table Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers 2014-2020
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2014
Figure Global Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2020
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers 2014-2020
Table Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2014
Figure Global Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2020
Table Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
Figure Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2014
Figure Global Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2020
Table Global Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
Figure Global Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers in 2014
Figure Global Radiopharmaceuticals in Nuclear Medicine Gross Margin in 2020
Figure Global Radiopharmaceuticals in Nuclear Medicine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table USA Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers 2014-2020
Table USA Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers 2014-2020
Figure USA Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2014
Figure USA Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2020
Table USA Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers 2014-2020
Table USA Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers 2014-2020
Figure USA Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2014
Figure USA Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2020
Table USA Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
Figure USA Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2014
Figure USA Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2020
Table USA Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
Figure USA Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers in 2014
Figure USA Radiopharmaceuticals in Nuclear Medicine Gross Margin in 2020
Figure USA Radiopharmaceuticals in Nuclear Medicine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers 2014-2020
Table Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers 2014-2020
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2014
Figure Europe Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2020
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers 2014-2020
Table Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2014
Figure Europe Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2020
Table Europe Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
Figure Europe Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2014
Figure Europe Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2020
Table Europe Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
Figure Europe Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers in 2014
Figure Europe Radiopharmaceuticals in Nuclear Medicine Gross Margin in 2020
Figure Europe Radiopharmaceuticals in Nuclear Medicine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Japan Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers 2014-2020
Table Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers 2014-2020
Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2014
Figure Japan Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2020
Table Japan Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers 2014-2020
Table Japan Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Japan Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2014
Figure Japan Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2020
Table Japan Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
Figure Japan Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2014
Figure Japan Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2020
Table Japan Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
Figure Japan Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers in 2014
Figure Japan Radiopharmaceuticals in Nuclear Medicine Gross Margin in 2020
Figure Japan Radiopharmaceuticals in Nuclear Medicine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Korea Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers 2014-2020
Table Korea Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers 2014-2020
Figure Korea Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2014
Figure Korea Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2020
Table Korea Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers 2014-2020
Table Korea Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Korea Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2014
Figure Korea Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2020
Table Korea Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
Figure Korea Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2014
Figure Korea Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2020
Table Korea Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
Figure Korea Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers in 2014
Figure Korea Radiopharmaceuticals in Nuclear Medicine Gross Margin in 2020
Figure Korea Radiopharmaceuticals in Nuclear Medicine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table India Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers 2014-2020
Table India Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers 2014-2020
Figure India Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2014
Figure India Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2020
Table India Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers 2014-2020
Table India Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers 2014-2020
Figure India Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2014
Figure India Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2020
Table India Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
Figure India Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2014
Figure India Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2020
Table India Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
Figure India Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers in 2014
Figure India Radiopharmaceuticals in Nuclear Medicine Gross Margin in 2020
Figure India Radiopharmaceuticals in Nuclear Medicine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers 2014-2020
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers 2014-2020
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2014
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2020
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers 2014-2020
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers 2014-2020
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2014
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2020
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2014
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2020
Table Southeast Asia Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers in 2014
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Gross Margin in 2020
Figure Southeast Asia Radiopharmaceuticals in Nuclear Medicine Market Concentration 2014-2020
Table Top 3 Sales Market Share (%) 2014-2020
Table Top 5 Sales Market Share (%) 2014-2020
Table Top 8 Sales Market Share (%) 2014-2020
Table South America Radiopharmaceuticals in Nuclear Medicine Sales (K Units) of Manufacturers 2014-2020
Table South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) of Manufacturers 2014-2020
Figure South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2014
Figure South America Radiopharmaceuticals in Nuclear Medicine Sales Market Share (%) in 2020
Table South America Radiopharmaceuticals in Nuclear Medicine Revenue (M USD) of Manufacturers 2014-2020
Table South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) of Manufacturers 2014-2020
Figure South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2014
Figure South America Radiopharmaceuticals in Nuclear Medicine Revenue Market Share (%) in 2020
Table South America Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers 2014-2020
Figure South America Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2014
Figure South America Radiopharmaceuticals in Nuclear Medicine Price (USD/Unit) of Manufacturers in 2020
Table South America Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers 2014-2020
Figure South America Radiopharmaceuticals in Nuclear Medicine Gross Margin of Manufacturers in 2014
Figure South America Radiopharmaceuticals in Nuclear Medicine Gross Margin in 2020
Figure South America Radiopharmaceuticals in Nuclear Medicine Market Concentration 2014-20

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs